Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.8%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now includes a new revision entry for v3.7.0 and removes the v3.6.6 entry, updating the version history shown on the page.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.6.6 is added to the study's history and the previous revision v3.6.5 is removed. This reflects an update to the page's version history rather than substantive changes to study data or content.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, and the previous revision v3.6.3 was removed, updating the version history displayed on the page.SummaryDifference0.1%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.